Frank Clyburn's Net Worth

$18 Million

Estimate Recalculated Nov 11, 2024 08:40AM EST

Who is Frank Clyburn?

Frank Clyburn has an estimated net worth of $18 Million. This is based on reported shares across multiple companies, which include DuPont de Nemours, Inc., INTERNATIONAL FLAVORS & FRAGRANCES INC, Merck & Co., Inc., and Revolution Medicines, Inc..

SEC CIK

Frank Clyburn's CIK is 0001763963

Past Insider Trading and Trends

2021 was Frank Clyburn's most active year for acquiring shares with 9 total transactions. Frank Clyburn's most active month to acquire stocks was the month of April. 2021 was Frank Clyburn's most active year for disposing of shares, totalling 9 transactions. Frank Clyburn's most active month to dispose stocks was the month of April. 2019 saw Frank Clyburn paying a total of $1,475,600.46 for 90,645 shares, this is the most they've acquired in one year. In 2021 Frank Clyburn cashed out on 124,537 shares for a total of $5,180,978.53, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DuPont de Nemours, Inc. (DD) Snapshot price: $79.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+37.87%
2.21K
$77.05
$170,049.35
8.03K
Apr 28
Form 4
+150.83%
3.44K
$49.46
$170,043.48
5.72K
May 27
Form 4
∞
2.24K
$76.10
$170,464.00
2.24K
Jun 3
Form 3
—
0
—
—
0
No matching records found

INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) Snapshot price: $103.01

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+118.32%
1K
$75.88
-$24,509.24
1.85K
Mar 1
Form 4
—
0
—
—
0
May 3
Form 4
∞
846
$91.64
-$43,712.28
846
Mar 1
Form 4
—
0
—
—
0
May 4
Form 4
—
0
—
—
0
Mar 1
Form 3
—
0
—
—
0
No matching records found

Merck & Co., Inc. (MRK) Snapshot price: $117.36

EVP & Pres ? Human Health

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 4
Form 4
+1.25%
1.2K
$87.96
-$3,388,571.19
97.1K
Oct 30 - Nov 1
Form 4
—
0
$78.32
-$1,513,440.22
94.35K
May 10
Form 4
+1.04%
967
$75.98
$73,472.66
94.35K
May 4
Form 4
+11.34%
9.43K
$72.62
$684,951.84
92.59K
Feb 26
Form 4
+1.41%
1.15K
$75.89
$87,273.50
82.52K
Oct 30
Form 4
—
0
$81.55
-$1,539,273.62
80.76K
Aug 5
Form 4
+3.68%
2.87K
$77.13
$221,370.66
80.76K
May 4 - May 5
Form 4
—
0
—
—
0
May 1
Form 4
+6.78%
4.91K
$76.56
$375,526.80
77.3K
Feb 28
Form 4
+1.64%
1.16K
$85.10
-$95,907.70
71.9K
Oct 30
Form 4
+3.29%
2.23K
$78.33
-$169,349.46
69.83K
May 10
Form 4
—
0
$58.51
-$960,932.50
67.6K
May 7
Form 4
+1.45%
966
$80.00
-$75,040.00
67.6K
May 3 - May 4
Form 4
+6.46%
4.02K
$80.38
$322,886.46
66.19K
Feb 25
Form 3
—
0
—
—
0
No matching records found

Revolution Medicines, Inc. (RVMD) Snapshot price: $41.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
6.93K
—
—
6.93K
Aug 5
Form 3
—
0
—
—
0
No matching records found

Cencora, Inc. (COR) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
368
$234.27
$86,211.36
368
Nov 1
No matching records found